Área de prevención cardiovascular y rehabilitación cardiaca
Duke Clinical Research Institute
Durham, Estados UnidosPublicaciones en colaboración con investigadores/as de Duke Clinical Research Institute (2)
2021
-
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial
Clinical Infectious Diseases, Vol. 73, Núm. 11, pp. 2009-2022
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529